Continuous subcutaneous insulin infusion revolutionized insulin delivery for people with type 1 diabetes. Researchers measured several devices and their effects on glycated hemoglobin levels, in addition to telehealth support, over a 3 month period.
Researchers conducted a study to determine whether toilet droplets generated during urinary are a vehicle for bacterial transmission and assess if the use of a novel foam spray decreases the risk for transmission.
Researchers examined the effect of implantable cardiac assistive devices on patients’ quality of life.
An increasing body of evidence suggests there may be ‘fetal origins’ of cardiovascular disease, and adverse conditions during pregnancy, including hypothyroidism, may play a role. A study following children born in Denmark to people with hypothyroidism during pregnancy explored this potential connection.
A uniform unguided de-escalation strategy significantly reduced bleeding events after index percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), according to findings from an open-label, assessor-masked randomized trial published in The Lancet. In the current study, researchers enrolled patients in the Ticagrelor Versus Clopidogrel in Stabilized Patients With AMI (TALOS-AMI) trial (ClinicalTrials.gov Identifier: NCT02018055),…
Researchers conducted a randomized clinical trial to assess the effects of lifestyle modifications on resistant hypertension.
Researchers sought to assess whether there is an association between maternal HIV drug resistance and an increased risk for vertical transmission and to describe the dynamics of drug resistance in infants with HIV infection.
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
Obesity rates and the incidence of malignant thyroid nodules have been increasing among younger patients in the US; there may be an association.
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.
